After years of waiting, the Bahamas are moving into the pilot phase of medical cannabis

After several years of regulatory preparation, the Bahamas are preparing to launch the first pilot phase of the medical cannabis rollout by the end of the year, in partnership with pharmacies in Nassau on the front lines.

This initial pilot program is intended to allow authorities and healthcare professionals to test the procedures before expanding them to the other islands in the archipelago.

Legalization is finally entering its implementation phase

The country has been working for several years the creation of a framework to guide usage medical, scientific, and religious cannabis.

A draft regulation introduced in 2023 included, among other things, rules regarding medical prescriptions, dispensing limits, and the maximum permitted THC concentration per dose. The text also includes specific provisions for religious use during Rastafarian ceremonies.

But between the adoption of a regulatory framework and the creation of a functional market, there were still several steps to take.

The Bahamas Cannabis Authority, which is responsible for overseeing the sector, is now working to make this system operational. In May, its president, Lynwood Brown, stated that the platform designed to manage licenses was complete and ready for the next phase of deployment.

A few months later, the timeline seems to be taking shape: an initial pilot phase is scheduled to take place before the end of the year.

Nassau will serve as the first testing ground

The rollout is not expected to cover the entire country immediately. The authorities have opted for a phased approach, with Nassau as the first pilot area.

Pharmacies in the capital must participate in this pilot phase to test how the new system works. This period will, in particular, help identify any potential issues with the procedures before they are rolled out in the Family Islands.

The implementation of the healthcare market is the focus of special attention from the Bahamas Pharmaceutical Association (BPA). The professional organization had already criticized the government on several aspects of the plan, including timelines, oversight of the sector, and the extent of consultation with professionals.

For the BPA, the issue of dispensing is central. Its president, Dr. Marvin Smith, advocates that products intended for patients should be considered and handled as medications, with a leading role entrusted to licensed pharmacists and mandatory training.

U.S. Tracking Data to Monitor the Industry

The system for tracking The authorities' decision is based, in particular, on METRC, a tracking system used in the United States to ensure product traceability throughout the regulated supply chain.

In the Bahamas, the platform is designed to track the various stages of the legal process, from administrative procedures to dispensing. It is also intended to handle electronic prescriptions and manage license applications.

For industry professionals, this infrastructure is essential for ensuring product traceability and enabling the regulatory authority to monitor movements within the supply chain.

No recreational market is expected

The ongoing legalization process primarily concerns the medical marijuana, as well as certain scientific and religious uses.

The government has no plans at this time to open a recreational market, as has been done on other Caribbean islands such as Saint Lucia or the Virgin Islands. The Bahamas, on the other hand, have studied the experiences of the Jamaica, Barbados or Saint Vincent and the Grenadines to adopt certain existing practices or adapt them to the legal and cultural context of the Bahamas.

A decisive step before expanding to the other islands

The pilot phase planned for Nassau will therefore be a full-scale test for the future market of the medical cannabis in the Bahamas.

If the program works as planned, the authorities will then be able to consider expanding it to the other islands in the archipelago. The lessons learned from the first participating pharmacies should make it possible to adjust the procedures, the training of healthcare professionals, and the platform’s operations.